Community Partnerships, New Installations, Voting Rights Disclosures, New Head Office Opening, and Price Revisions - Analyst Notes on Berkeley, James Fisher, Severn Trent, Synergy and Dairy Crest

LONDON, June 5, 2014 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Earnings Review released its analysts' notes regarding Berkeley Group Holding Plc (LON: BKG), James Fisher & Sons Group Plc (LON: FSJ), Severn Trent Plc (LON: SVT), Synergy Health Plc (LON: SYR) and Dairy Crest Group Plc (LON: DCG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://earnings-review.com/3384-100free.

--
Berkeley Group Holding Plc Analyst Notes
On May 6, 2014, Berkeley Group Holding Plc (Berkeley) informed that the Woodberry Down Regeneration Programme, which celebrated its fifth anniversary in 2014, will deliver over 5,500 new homes for London, of which 41% will be affordable. The project, which began in March 2009 at the height of global recession, will deliver the new homes in partnership with Berkeley Homes, the London Borough of Hackney, Greater London Authority, Genesis Housing Association and Woodberry Down Community Organisation (WDCO). Tony Pidgley CBE, Chairman, Berkeley, said, "We have achieved something here because we found a way to collaborate. Collaboration between the public and private sectors is fundamental. It lies at the heart of all good development. We need much more of this kind of partnership working, if we're going to tackle the housing challenge." The full analyst notes on Berkeley are available to download free of charge at:

http://earnings-review.com/3384-BKG-05Jun2014.pdf

--
James Fisher & Sons Group Plc Analyst Notes
On May 21, 2014, James Fisher & Sons Group Plc (James Fisher) announced that its subsidiary Strainstall has successfully installed its Vessel Motion Monitoring System (VMMS) on a vessel running trials for the Carbon Trust Offshore Wind Accelerator (OWA) programme. Carbon Trust's OWA programme is a joint industry program aiming to reduce the cost of offshore wind by 10% for UK Round 3 sites. The Company stated that VMMS is supporting the Carbon Trust during prototype testing phases to quantify vessel conditions during personnel transfers. Scott Cruttenden, Business Development Manager, Strainstall, commented, "We are delighted to be supporting the Carbon Trust in the latest OWA concept trial. VMMS is being widely used across the offshore wind and oil and gas industries and there seems to be a more pragmatic approach towards implementing solutions that can facilitate cost effective operations whilst enhancing safety levels." The full analyst notes on James Fisher are available to download free of charge at:

http://earnings-review.com/3384-FSJ-05Jun2014.pdf

--
Severn Trent Plc Analyst Notes
On June 2, 2014, Severn Trent Plc (Severn Trent) announced its voting rights and capital in accordance with Disclosure and Transparency Rule 5.6.1. The Company informed that as at June 2, 2014, the Company's issued share capital consisted of 239,514,081 ordinary shares each with voting rights. The Company stated that it held no shares in Treasury and, hence, the total number of voting rights in Severn Trent was 239,514,081. The full analyst notes on Severn Trent are available to download free of charge at:

http://earnings-review.com/3384-SVT-05Jun2014.pdf

--
Synergy Health Plc Analyst Notes
On June 2, 2014, Synergy Health Plc (Synergy) announced the opening of its new head office in Derby by the local MP, Margaret Beckett, who also paid a visit to the Company's Sterile Service facility at the Royal Derby Hospital. The Company informed that Margaret Beckett also received a special behind the scenes tour, showing Synergy's reusable surgical instrument sterilization services. Adrian Coward, Chief Operating Officer, commented, "The new site is testament to the growth of the company and points to an exciting future. We feel very strongly that the cost savings demanded in the healthcare sector do not need to impact the standards of sterile services or compromise patient safety." The full analyst notes on Synergy are available to download free of charge at:

http://earnings-review.com/3384-SYR-05Jun2014.pdf

--
Dairy Crest Group Plc Analyst Notes
On May 30, 2014, Dairy Crest Group Plc (Dairy Crest) announced a price reduction of 1.25 ppl for farmers on standard liquid contracts from July 1, 2014. The revised price for liquid milk will be 31.2 ppl, while the price paid to farmers on Davidstow cheese contract will remain unchanged. Dairy Crest said the reduction in price paid to farmers for milk reflected market conditions, with high levels of production and reduced dairy market returns. Mike Sheldon, Procurement Director, Dairy Crest, said, "I recognise a price decrease is disappointing for our farmers but we have delivered on our commitment to strive for stable pricing by adjusting the price by less and later than our competitors. I am pleased to deliver further stability on our cheese price for Davidstow farmers. As our successful Cathedral City and Davidstow cheese brands continue to grow, we need more milk for our Davidstow Creamery." The full analyst notes on Dairy Crest are available to download free of charge at:

http://earnings-review.com/3384-DCG-05Jun2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] earnings-review.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] earnings-review.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] earnings-review.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Earnings Review in this article or report according to the procedures outlined by Earnings Review. Earnings Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Earnings Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Earnings Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.